BackLumiraDx Limited - Units (1 Ord Class A & 1/2 War) Overview

LumiraDx Limited - Units (1 Ord Class A & 1/2 War) Total Liabilities

Track LumiraDx Limited - Units (1 Ord Class A & 1/2 War)'s total liabilities ($14M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$13.80M

Peer trimmed avg / median

Loading

LumiraDx Limited - Units (1 Ord Class A & 1/2 War) Total Liabilities History

Loading

LumiraDx Limited - Units (1 Ord Class A & 1/2 War) vs. peers: Total Liabilities Comparison

Loading

LumiraDx Limited - Units (1 Ord Class A & 1/2 War) Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

LumiraDx Limited - Units (1 Ord Class A & 1/2 War) (CAHCU) FAQ

LumiraDx Limited - Units (1 Ord Class A & 1/2 War)'s total liabilities stands at $14M as of June 2021. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Open the history chart to see whether LumiraDx Limited - Units (1 Ord Class A & 1/2 War)'s total liabilities is expanding or contracting. Sustained growth in total liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how LumiraDx Limited - Units (1 Ord Class A & 1/2 War)'s total liabilities evolved across reporting periods, while the comparison chart places CAHCU next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, total liabilities is commonly used to spot outliers. LumiraDx Limited - Units (1 Ord Class A & 1/2 War)'s reading of $14M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.